Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000462228 | SCV000560015 | benign | Gorlin syndrome | 2025-01-23 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316614 | SCV004017186 | benign | Basal cell carcinoma, susceptibility to, 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003409646 | SCV004123747 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | PTCH2: BP4, BP7 |
Breakthrough Genomics, |
RCV003409646 | SCV005281432 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004551559 | SCV004785244 | likely benign | PTCH2-related disorder | 2019-09-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |